| Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 6814 | 2011 |
| Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death C Dumontet, BI Sikic Journal of Clinical Oncology 17 (3), 1061-1061, 1999 | 743 | 1999 |
| Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity JP Marie, R Zittoun, BI Sikic | 523 | 1991 |
| Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations WT Beck, TM Grogan, CL Willman, C Cordon-Cardo, DM Parham, ... Cancer research 56 (13), 3010-3020, 1996 | 506 | 1996 |
| Gene expression patterns in ovarian carcinomas ME Schaner, DT Ross, G Ciaravino, T Sørlie, O Troyanskaya, M Diehn, ... Molecular biology of the cell 14 (11), 4376-4386, 2003 | 443 | 2003 |
| First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers BI Sikic, N Lakhani, A Patnaik, SA Shah, SR Chandana, D Rasco, ... Journal of Clinical Oncology 37 (12), 946, 2019 | 434 | 2019 |
| Detection of cell-affecting agents with a silicon biosensor JW Parce, JC Owicki, KM Kercso, GB Sigal, HG Wada, VC Muir, ... Science 246 (4927), 243-247, 1989 | 407 | 1989 |
| Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas M Bredel, C Bredel, D Juric, GR Harsh, H Vogel, LD Recht, BI Sikic Cancer research 65 (19), 8679-8689, 2005 | 360 | 2005 |
| Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein BI Sikic, GA Fisher, BL Lum, J Halsey, L Beketic-Oreskovic, G Chen Cancer chemotherapy and pharmacology 40, S13-S19, 1997 | 356 | 1997 |
| Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. BL Lum, S Kaubisch, AM Yahanda, KM Adler, L Jew, MN Ehsan, ... Journal of Clinical Oncology 10 (10), 1635-1642, 1992 | 351 | 1992 |
| Modulation of multidrug resistance: at the threshold. BI Sikic Journal of Clinical Oncology 11 (9), 1629-1635, 1993 | 317* | 1993 |
| NFKBIA deletion in glioblastomas M Bredel, DM Scholtens, AK Yadav, AA Alvarez, JJ Renfrow, JP Chandler, ... New England Journal of Medicine 364 (7), 627-637, 2011 | 288 | 2011 |
| Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase … PL Greenberg, SJ Lee, R Advani, MS Tallman, BI Sikic, L Letendre, ... Journal of clinical oncology: official journal of the American Society of …, 2004 | 283 | 2004 |
| Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA WG Harker, BI Sikic Cancer research 45 (9), 4091-4096, 1985 | 283 | 1985 |
| Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. AM Yahanda, KM Alder, GA Fisher, NA Brophy, J Halsey, RI Hardy, ... Journal of clinical oncology 10 (10), 1624-1634, 1992 | 256 | 1992 |
| Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. S Weber, JE Zuckerman, DG Bostwick, KG Bensch, BI Sikic, TA Raffin The Journal of clinical investigation 75 (1), 306-309, 1985 | 256 | 1985 |
| Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion JJ Gullo, CL Litterst, PJ Maguire, BI Sikic, DF Hoth, PV Woolley Cancer chemotherapy and pharmacology 5, 21-26, 1980 | 248 | 1980 |
| Molecular pathways: regulation and therapeutic implications of multidrug resistance KG Chen, BI Sikic Clinical cancer research 18 (7), 1863-1869, 2012 | 246 | 2012 |
| A network model of a cooperative genetic landscape in brain tumors M Bredel, DM Scholtens, GR Harsh, C Bredel, JP Chandler, JJ Renfrow, ... Jama 302 (3), 261-275, 2009 | 241 | 2009 |
| Liposomal protection of adriamycin-induced cardiotoxicity in mice A Rahman, A Kessler, N More, B Sikic, G Rowden, P Woolley, PS Schein Cancer research 40 (5), 1532-1537, 1980 | 239 | 1980 |
